Gabryś Dorota, Dörfler Annegret, Yaromina Ala, Hessel Franziska, Krause Mechthild, Oertel Reinhard, Baumann Michael
Department of Radiation Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland.
Strahlenther Onkol. 2008 Jan;184(1):48-53. doi: 10.1007/s00066-008-1805-7.
To evaluate the effect of lovastatin alone or combined with radiation on U87MG and FaDu cells in vitro and U87MG tumors in vivo.
Cell number, p21(WAF1) expression, apoptosis, reproductive cell death, and cell-cycle distribution were investigated after incubation of U87MG and FaDu cells in vitro. The effect of lovastatin (50 mg/kg/day) on tumor growth and on tumor growth delay after single-dose irradiation with 20 Gy was investigated using U87MG tumors in nude mice.
Lovastatin dose dependently decreased cell number and proliferation of U87MG and FaDu cells. The proportion of cells in G0/G1 phase, apoptosis and p21 protein expression increased after lovastatin alone or combined with 4-Gy irradiation in both cell lines. Effects of lovastatin on cell cycle and cell number were more pronounced in U87MG compared to FaDu. No radiosensitization of clonogenic cells by lovastatin could be demonstrated in both cells lines, but the colony-forming ability after lovastatin alone was decreased in FaDu cells. In vivo, lovastatin decreased tumor volume over time but did not increase growth delay after irradiation of U87MG tumors with 20 Gy.
The data support effects of lovastatin on proliferation, apoptosis and colony-forming ability in vitro and tumor volume in vivo. At the drug concentration achievable, lovastatin did not improve the effects of radiation on U87MG tumors in vivo.
评估洛伐他汀单独使用或与放疗联合使用对体外培养的U87MG和FaDu细胞以及体内U87MG肿瘤的影响。
体外培养U87MG和FaDu细胞后,研究细胞数量、p21(WAF1)表达、凋亡、生殖细胞死亡和细胞周期分布。使用裸鼠体内的U87MG肿瘤研究洛伐他汀(50mg/kg/天)对肿瘤生长及单次20Gy照射后肿瘤生长延迟的影响。
洛伐他汀剂量依赖性地降低U87MG和FaDu细胞的数量及增殖。单独使用洛伐他汀或与4Gy照射联合使用后,两种细胞系中处于G0/G1期的细胞比例、凋亡率及p21蛋白表达均增加。与FaDu细胞相比,洛伐他汀对U87MG细胞周期和细胞数量的影响更明显。在两种细胞系中均未证实洛伐他汀对克隆形成细胞有放射增敏作用,但单独使用洛伐他汀后FaDu细胞的集落形成能力下降。在体内,洛伐他汀随时间推移可减小肿瘤体积,但对20Gy照射后的U87MG肿瘤未增加生长延迟。
数据支持洛伐他汀对体外增殖、凋亡和集落形成能力以及体内肿瘤体积的影响。在可达到的药物浓度下,洛伐他汀未改善放疗对体内U87MG肿瘤的效果。